Metastasiertes blasenkarzinom in der zweitlinienbehandlung

M. Retz; C. Bokemeyer

doi:10.1007/s00761-012-2299-6

Metastasiertes blasenkarzinom in der zweitlinienbehandlung

Translated title of the contribution: Second-line therapy of metastatic bladder cancer

M. Retz, C. Bokemeyer

Department of Urology

University Medical Center Hamburg-Eppendorf

Research output: Contribution to journal › Article › peer-review

Abstract

This article summarizes the contemporary standards as well as updated study results for second-line systemic therapy for metastatic and urothelial carcinoma pretreated with cisplatin. Furthermore, new prognostic factors in the second-line treatment of urothelial cancers are presented.

Translated title of the contribution	Second-line therapy of metastatic bladder cancer
Original language	German
Pages (from-to)	1018-1022
Number of pages	5
Journal	Onkologe
Volume	18
Issue number	11
DOIs	https://doi.org/10.1007/s00761-012-2299-6
State	Published - Nov 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00761-012-2299-6

Cite this

@article{12aa0df214fe47cbae3f16af0f5f6f98,

title = "Metastasiertes blasenkarzinom in der zweitlinienbehandlung",

abstract = "This article summarizes the contemporary standards as well as updated study results for second-line systemic therapy for metastatic and urothelial carcinoma pretreated with cisplatin. Furthermore, new prognostic factors in the second-line treatment of urothelial cancers are presented.",

keywords = "Bladder cancer, Prognostic factors, Second-line chemotherapy, Systemic chemotherapy, Urothelial carcinoma",

author = "M. Retz and C. Bokemeyer",

year = "2012",

month = nov,

doi = "10.1007/s00761-012-2299-6",

language = "Deutsch",

volume = "18",

pages = "1018--1022",

journal = "Onkologe",

issn = "0947-8965",

publisher = "Springer Medizin",

number = "11",

}

TY - JOUR

T1 - Metastasiertes blasenkarzinom in der zweitlinienbehandlung

AU - Retz, M.

AU - Bokemeyer, C.

PY - 2012/11

Y1 - 2012/11

N2 - This article summarizes the contemporary standards as well as updated study results for second-line systemic therapy for metastatic and urothelial carcinoma pretreated with cisplatin. Furthermore, new prognostic factors in the second-line treatment of urothelial cancers are presented.

AB - This article summarizes the contemporary standards as well as updated study results for second-line systemic therapy for metastatic and urothelial carcinoma pretreated with cisplatin. Furthermore, new prognostic factors in the second-line treatment of urothelial cancers are presented.

KW - Bladder cancer

KW - Prognostic factors

KW - Second-line chemotherapy

KW - Systemic chemotherapy

KW - Urothelial carcinoma

UR - http://www.scopus.com/inward/record.url?scp=84868626940&partnerID=8YFLogxK

U2 - 10.1007/s00761-012-2299-6

DO - 10.1007/s00761-012-2299-6

M3 - Artikel

AN - SCOPUS:84868626940

SN - 0947-8965

VL - 18

SP - 1018

EP - 1022

JO - Onkologe

JF - Onkologe

IS - 11

ER -

Metastasiertes blasenkarzinom in der zweitlinienbehandlung

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this